Fundz

Setara Biosciences, Inc. raised $90 million in a Series A financing to advance precision medicines for rare genetic diseases.

PRIVATEOct 30, 2026

Amount Raised

$90 Million

Round Type

Series A

San DiegoBiotechnologyHealth CareTherapeutics

Investors

Jazz PharmaceuticalsRegeneron VenturesEuclidean CapitalEcoR1Droia VenturesCanaanDeerfield Management

Description

Setara Biosciences, Inc. has completed a $90 million Series A financing. The company focuses on developing precision medicines for severe rare diseases. This funding will support the advancement of its pipeline, including investigational therapies for specific genetic conditions.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Setara Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Lifeplex Science raised $5.3M (Series A) on November 13, 2026.
  • Orakl Oncology raised $34M (Series A) on November 12, 2026.
  • Neurosterix raised $105M (Series B) on November 11, 2026.
  • VectorY raised $83M on November 11, 2026.
  • Oyster Therapeutics raised $60M (Series A) on November 10, 2026.
  • SRTD biotech raised $35M (Seed) on November 9, 2026.

Who to call at Setara Biosciences, and when

A new round usually means Setara Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Setara Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Setara Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Setara Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Setara Biosciences

Location

San Diego, California, United States

About

Setara Biosciences, Inc. is a clinical-stage biotechnology company that leverages genetics to develop precision medicines for severe rare diseases. The company was formed after Jazz Pharmaceuticals acquired Actio Biosciences. Its lead program is ABS-1230, an investigational therapy for KCNT1-related epilepsy.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Setara Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Setara Biosciences's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Setara Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.